Wall Street brokerages expect that Cardinal Health, Inc. (NYSE:CAH) will post earnings per share (EPS) of $1.14 for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Cardinal Health’s earnings. The lowest EPS estimate is $1.01 and the highest is $1.21. Cardinal Health reported earnings per share of $1.34 during the same quarter last year, which would suggest a negative year-over-year growth rate of 14.9%. The company is expected to report its next quarterly earnings report on Tuesday, February 6th.

On average, analysts expect that Cardinal Health will report full-year earnings of $4.96 per share for the current financial year, with EPS estimates ranging from $4.85 to $5.00. For the next year, analysts expect that the firm will post earnings of $5.50 per share, with EPS estimates ranging from $5.37 to $5.60. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that cover Cardinal Health.

Cardinal Health (NYSE:CAH) last released its earnings results on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.09. The company had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. Cardinal Health’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.24 earnings per share.

Several equities analysts have weighed in on CAH shares. Morgan Stanley lowered Cardinal Health from an “equal weight” rating to an “underweight” rating in a report on Monday, November 20th. Argus lowered Cardinal Health from a “buy” rating to a “hold” rating in a report on Wednesday, November 15th. Mizuho set a $70.00 price objective on Cardinal Health and gave the company a “hold” rating in a report on Tuesday, October 24th. Zacks Investment Research raised Cardinal Health from a “sell” rating to a “hold” rating in a report on Wednesday, November 8th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardinal Health in a report on Sunday, September 10th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $73.91.

Cardinal Health (NYSE CAH) opened at $63.19 on Friday. The stock has a market capitalization of $18,986.33, a P/E ratio of 11.45, a PEG ratio of 1.75 and a beta of 0.85. The company has a quick ratio of 0.52, a current ratio of 1.06 and a debt-to-equity ratio of 1.35. Cardinal Health has a twelve month low of $54.66 and a twelve month high of $84.88.

The business also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Tuesday, January 2nd will be given a dividend of $0.4624 per share. The ex-dividend date is Friday, December 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.93%. Cardinal Health’s dividend payout ratio is currently 53.78%.

Large investors have recently bought and sold shares of the business. Brandes Investment Partners LP purchased a new stake in shares of Cardinal Health during the second quarter worth $2,464,000. Victory Capital Management Inc. lifted its position in shares of Cardinal Health by 202.1% during the second quarter. Victory Capital Management Inc. now owns 61,304 shares of the company’s stock worth $4,776,000 after acquiring an additional 41,013 shares in the last quarter. Dupont Capital Management Corp purchased a new stake in shares of Cardinal Health during the second quarter worth $164,000. Swiss National Bank lifted its position in shares of Cardinal Health by 1.6% during the second quarter. Swiss National Bank now owns 1,152,648 shares of the company’s stock worth $89,814,000 after acquiring an additional 18,600 shares in the last quarter. Finally, FDx Advisors Inc. lifted its position in shares of Cardinal Health by 7.9% during the third quarter. FDx Advisors Inc. now owns 43,508 shares of the company’s stock worth $2,912,000 after acquiring an additional 3,172 shares in the last quarter. Hedge funds and other institutional investors own 88.47% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Analysts Anticipate Cardinal Health, Inc. (CAH) Will Post Earnings of $1.14 Per Share” was published by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/12/17/analysts-anticipate-cardinal-health-inc-cah-will-post-earnings-of-1-14-per-share.html.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Get a free copy of the Zacks research report on Cardinal Health (CAH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.